Par Pharmaceutical Reports Third-Quarter 20...(CONDENSED CONSOLIDATED BALANCE SHEETS .....),Health

(In Thousands, Except Share Data)

(Unaudited)

September 29, December 31,

ASSETS 2007 2006

Current assets:

Cash and cash equivalents $114,161 $120,991

Available for sale debt and marketable

equity securities 173,544 92,120

Accounts receivable, net 108,182 99,043

Inventories 81,049 106,322

Prepaid expenses and other current assets 13,623 15,833

Deferred income tax assets 72,105 72,105

Income taxes receivable 6,605 12,422

Total current assets 569,269 518,836

Property, plant and equipment, at cost

less accumulated depreciation and

amortization 81,902 89,155

Available for sale debt and marketable

equity securities 7,233 7,652

Investment in joint venture 5,774 5,292

Other investments 2,500 16,588

Intangible assets, net 38,719 47,880

Goodwill 63,729 63,729

Deferred charges and other assets 2,879 16,000

Non-current deferred income tax assets, net 57,485 49,545

Total assets $829,490 $814,677

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Short-term and current portion of

'/>"/>